Skip to main content

Advertisement

Table 5 Mean (SD) annualized health-care costs (in dollars) for patients by second-step interventions

From: What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

  MDD-related Non-MDD-related Overall
Inpatient Outpatient ER Total MDD Inpatient Outpatient ER Total non-MDD  
Mean (SD) Mean (SD) Mean (SD)
Continued 165 (1,980) 1,163 (1,496) 5 (77) 1,333 (2,567) 1,129 (6,949) 3,790 (8,701) 158 (674) 5,077 (12,608) 7,916 (14,008)
Discontinued 490 (5,252) 1,207 (1,532) 16 (154) 1,714 (5,519) 1,441 (8,015) 4,735 (16,492) 250 (752) 6,426 (20,217) 9,263 (23,459)
Switch 635 (4,036) 1,594 (2,909) 17 (202) 2,246 (5,644) 2,401 (12,878) 5,103 (8,306) 313 (1,011) 7,817 (18,516) 12,189 (20,863)
Add-on 1,074 (6,873) 1,859 (4,171) 21 (324) 2,954 (8,390) 2,701 (19,719) 6,235 (13,461) 365 (1,494) 9,301 (26,426) 14,514 (30,044)
Wilcoxon P value A, B, C, D, E A, B, C, D, E C, E, F A, B, C, D, E, F B, C, D, E B, C, D, E C, D, E, F B, C, D, E A, B, C, D, E
  1. A difference between switched and added cohort is statistically significant (P < 0.05), B difference between switched and discontinued cohort is statistically significant (P < 0.05), C difference between switched and continued cohort is statistically significant (P < 0.05), D difference between added and discontinued cohort is statistically significant (P < 0.05), E difference between added and continued cohort is statistically significant (P < 0.05), F difference between discontinued and continued cohort is statistically significant (P < 0.05).